» Articles » PMID: 35247021

Evaluating Opioid Analgesic Prescribing Limits: A Narrative Review

Overview
Publisher Wiley
Date 2022 Mar 5
PMID 35247021
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In response to the opioid crisis, opioid analgesic guidelines and prescribing limits have proliferated. The purpose of this narrative review is to examine evidence from studies evaluating the patient or public health impact of federal and state opioid analgesic prescribing guidelines and laws, describe gaps and challenges in current research, and highlight opportunities for improving future research.

Methods: We focused on evidence from a literature review covering 2013 through 2019. We identified 30 studies evaluating opioid analgesic thresholds based on federal policies and guidelines, state laws, and Medicaid state plans that attempt to influence the course of patient care at or when the limit is exceeded (e.g., prior authorization).

Results: Most studies evaluated changes in prescribing or dispensing patterns of opioid analgesics, largely finding decreases in prescribing after policy enactment. Fewer studies evaluated patient or public health outcomes beyond changes in prescribing and dispensing patterns; results were infrequently stratified by potentially important sociodemographic and clinical factors. No studies assessed the potential for adverse patient outcomes for which we have emerging evidence of harms.

Conclusions: We describe knowledge gaps and propose opportunities for future research to sufficiently assess the potential impact and unintended consequences of opioid analgesic prescribing laws, regulations, guidelines, and policies.

Citing Articles

Impacts of State-Level Opioid Review Programs on Injured Workers and Their Health Care Providers: A Qualitative Study in Washington and Ohio.

Padamsee T, Montgomery C, Kienzle S, Straughn J, Elmore A, Fulton-Kehoe D Milbank Q. 2024; 102(3):605-631.

PMID: 38861655 PMC: 11576590. DOI: 10.1111/1468-0009.12705.


Trajectories and predictors of high-occurrence pain flares in ambulatory cancer patients on opioids.

Meghani S, Quinn R, Robinson A, Chittams J, Vapiwala N, Naylor M JNCI Cancer Spectr. 2024; 8(1).

PMID: 38268502 PMC: 10880071. DOI: 10.1093/jncics/pkae003.


Associations Between Management Pathway and Opioid Prescriptions for Patients Entering the Emergency Department With Neck and Back Pain.

Horn M, Simon C, Lee H, Eucker S Mayo Clin Proc Innov Qual Outcomes. 2023; 7(5):490-498.

PMID: 37842687 PMC: 10568062. DOI: 10.1016/j.mayocpiqo.2023.08.001.


A multi-disciplinary program for opioid sparse arthroplasty results in reduced long-term opioid consumption: a four year prospective study.

Lin D, Samson A, DMello F, Brown B, Cehic M, Wilson C BMC Anesthesiol. 2023; 23(1):97.

PMID: 36991313 PMC: 10050824. DOI: 10.1186/s12871-023-02062-8.

References
1.
Haegerich T, Jones C, Cote P, Robinson A, Ross L . Evidence for state, community and systems-level prevention strategies to address the opioid crisis. Drug Alcohol Depend. 2019; 204:107563. PMC: 9286294. DOI: 10.1016/j.drugalcdep.2019.107563. View

2.
. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. MMWR Morb Mortal Wkly Rep. 2011; 60(43):1487-92. View

3.
Chen Q, Hsia H, Overman R, Bryan W, Pepin M, Mariano E . Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series Analysis. Anesthesiology. 2019; 131(2):369-380. DOI: 10.1097/ALN.0000000000002771. View

4.
Schuler M, Griffin B, Cerda M, McGinty E, Stuart E . Methodological Challenges and Proposed Solutions for Evaluating Opioid Policy Effectiveness. Health Serv Outcomes Res Methodol. 2021; 21(1):21-41. PMC: 8057700. DOI: 10.1007/s10742-020-00228-2. View

5.
Meara E, Horwitz J, Powell W, McClelland L, Zhou W, OMalley A . State Legal Restrictions and Prescription-Opioid Use among Disabled Adults. N Engl J Med. 2016; 375(1):44-53. PMC: 4985562. DOI: 10.1056/NEJMsa1514387. View